Drosulfakinin
Drosulfakinin has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 11, 2023: “The neuropeptide drosulfakinin enhances choosiness and protects males from the aging effects of social perception”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute on Aging and 2 more
- Model organisms1
What did studies of Drosulfakinin find?
2Studies of Drosulfakinin measured 2 outcomes; the most studied are mate choosiness (1 study) and lifespan (1).
Mate choosiness
upin flies1
1 study
Mate choosiness
upin flies1
Drosulfakinin improves mate choosiness in flies.
“Surprisingly, this effect was not caused by insulins themselves, but instead by drosulfakinin (DSK), another neuropeptide produced in a subset of the IPCs, acting through one of the two DSK receptors, CCKLR-17D1.”
Model organismsmales
Proceedings of the National Academy of Sciences of the United States of America
Lifespan
upin flies1
1 study
Lifespan
upin flies1
Drosulfakinin extends lifespan in flies.
“Broader activation of Dsk+ neurons (both within and outside of the IPCs) was required to rescue the detrimental effect of female pheromone exposure on male lifespan”
Model organismsfemale pheromone exposuremales
Proceedings of the National Academy of Sciences of the United States of America